Skip to main content

Table 2 Odds ratio and 95% CI of each component of MetS at 3-year follow-up according to baseline hemoglobin quartiles in men

From: Hemoglobin concentration is associated with the incidence of metabolic syndrome

MetS

Q1 (< 150 g/L)

Q2 (150–157 g/L)

Q3 (158–163 g/L)

Q4 (≥164 g/L)

n = 314

n = 351

n = 367

n = 360

Incidence, n (%)

8 5 (24.9)

90 (25.6)

115 (31.3)

121 (33.6)

Model 1

1 (Ref)

1.04 (0.74–1.45)

1.37 (0.99–1.91)

1.53 (1.10–2.12) *

Model 2

1 (Ref)

1.05 (0.74–1.49)

1.35 (0.96–1.90)

1.50 (1.06–2.11) *

Model 3†

1 (Ref)

0.84 (0.57–1.25)

1.03 (0.70–1.53)

1.11 (0.75–1.65)

WC

Q1 (< 151 g/L)

Q2 (151–157 g/L)

Q3 (158–164 g/L)

Q4 (≥165 g/L)

n = 347

n = 324

n = 322

n = 311

Incidence, n (%)

87 (25.1)

96 (29.6)

107 (33.2)

109 (35.0)

Model 1

1 (Ref)

1.26 (0.90–1.77)

1.49 (1.06–2.08) *

1.61 (1.15–2.26) *

Model 2

1 (Ref)

1.28 (0.90–1.82)

1.60 (1.13–2.26) *

1.75 (1.23–2.49) *

Model 3‡

1 (Ref)

1.21 (0.83–1.75)

1.58 (1.09–2.28) *

1.65 (1.12–2.43) *

BP

Q1 (< 150 g/L)

Q2 (150-156g/L)

Q3 (157-162g/L)

Q4 (≥163 g/L)

n = 168

n = 160

n = 175

n = 185

Incidence, n (%)

88 (52.4)

68 (42.5)

91 (52.0)

105 (56.8)

Model 1

1 (Ref)

0.67 (0.44–1.04)

0.99 (0.65–1.51)

1.19 (0.78–1.82)

Model 2

1 (Ref)

0.67 (0.43–1.04)

1.04 (0.67–1.61)

1.28 (0.83–2.00)

Model 3§

1 (Ref)

0.76 (0.47–1.23)

1.09 (0.67–1.74)

1.24 (0.76–2.00)

TGs

Q1 (< 150 g/L)

Q2 (150-156g/L)

Q3 (157-163g/L)

Q4 (≥164 g/L)

n = 379

n = 360

n = 378

n = 361

Incidence, n (%)

68 (17.9)

60 (16.7)

76 (20.1)

79 (21.9)

Model 1

1 (Ref)

0.92 (0.62–1.34)

1.15 (0.80–1.65)

1.28 (0.89–1.84)

Model 2

1 (Ref)

0.90 (0.61–1.33)

1.07 (0.74–1.57)

1.20 (0.83–1.75)

Model 3¶

1 (Ref)

0.94 (0.60–1.45)

0.96 (0.62–1.48)

1.23 (0.80–1.89)

HDL-c

Q1 (< 151 g/L)

Q2 (151-157g/L)

Q3 (158-164g/L)

Q4 (≥165 g/L)

n = 384

n = 395

n = 415

n = 406

Incidence, n (%)

36 (9.4)

48 (12.2)

54 (13.0)

57 (14.0)

Model 1

1 (Ref)

1.33 (0.84–2.09)

1.43 (0.92–2.24)

1.57 (1.01–2.44) *

Model 2

1 (Ref)

1.19 (0.75–1.91)

1.37 (0.87–2.16)

1.51 (0.96–2.38)

Model 3††

1 (Ref)

1.10 (0.66–1.82)

1.18 (0.72–1.94)

1.23 (0.75–2.03)

FBG

Q1 (< 149 g/L)

Q2 (149-156g/L)

Q3 (157-163g/L)

Q4 (≥164 g/L)

 

n = 149

n = 134

n = 141

n = 137

Incidence, n (%)

48 (38.1)

43 (32.1)

53 (37.6)

42 (30.7)

Model 1

1 (Ref)

0.77 (0.46–1.28)

0.98 (0.60–1.61)

0.72 (0.43–1.20)

Model 2

1 (Ref)

0.85 (0.50–1.44)

0.98 (0.58–1.66)

0.74 (0.43–1.27)

Model 3‡‡

1 (Ref)

0.88 (0.47–1.66)

1.00 (0.54–1.89)

0.76 (0.39–1.49)

  1. Abbreviations: CI, confidential interval; WC, waist circumference; DBP, diastolic blood pressure; SBP, systolic blood pressure; FPG, fasting plasma glucose; HDL-c, high-density lipoprotein cholesterol; TGs, triglycerides; eGFR, estimated glomerular filtration rate; the use of bold emphasis and * are to mark the statistically significant indicators
  2. Model 1 is unadjusted;
  3. Model 2 is adjusted for age, education, smoking and drinking;
  4. Model 3† is adjusted for age, education, smoking, drinking, WC, SBP, DBP, FPG, HDL-c, TGs, uric acid, NAFLD and eGFR
  5. Model 3‡ is adjusted for age, education, smoking, drinking, SBP, DBP, FPG, HDL-c, TGs, uric acid, NAFLD and eGFR
  6. Model 3§ is adjusted for age, education, smoking, drinking, WC, FPG, HDL-c, TGs, uric acid, NAFLD and eGFR
  7. Model 3¶ is adjusted for age, education, smoking, drinking, WC, SBP, DBP, FPG, HDL-c, uric acid, NAFLD and eGFR
  8. Model 3†† is adjusted for age, education, smoking, drinking, WC, SBP, DBP, FPG, TGs, uric acid, NAFLD and eGFR
  9. Model 3‡‡ is adjusted for age, education, smoking, drinking, WC, SBP, DBP, HDL-c, TGs, uric acid, NAFLD and eGFR